If you find yourself asking, “Why am I not losing weight on semaglutide?“—you’re not alone. Semaglutide, known by brand names such as Ozempic, Wegovy, and Rybelsus, has become popular for its effectiveness in promoting weight loss and managing Type 2 diabetes.
Semaglutide works by mimicking the GLP-1 hormone, which helps suppress appetite, regulate blood sugar, and reduce calorie intake. While many people experience significant weight loss with this medication, you might feel frustrated if the results aren’t meeting your expectations.
If you’ve been using semaglutide but aren’t losing weight as quickly or effectively as you’d hoped, several factors could be at play. Let’s explore 10 possible reasons why you’re not losing weight on semaglutide and what you can do to overcome these challenges.
Why Am I Not Losing Weight on Semaglutide?
Here are 10 reasons why you might not be losing weight on semaglutide:
1. Your Semaglutide Dosage Might Be Too Low
One common reason you’re not losing weight on semaglutide is that your dosage might be too low. The dosage of semaglutide varies depending on whether it’s used for weight loss or diabetes management.
For instance, Wegovy, approved specifically for weight loss, usually starts at a low dose of 0.25 mg per week. Over time, this increases to a recommended maintenance dose of 1.7 mg or 2.4 mg per week, depending on how well it’s tolerated. Ozempic, primarily prescribed for diabetes but often used off-label for weight loss, also starts at 0.25 mg per week. Its maximum dose for blood sugar control is 1 mg or 2 mg per week.
In a study, patients who received the highest doses of semaglutide (1.7 and 2.4 mg) lost an average of 6.9% of their body weight in 3 months. In comparison, patients on lower doses (0.25, 0.5, and 1 mg) lost 5.1% on average.
At 6 months, patients on higher doses achieved a mean weight loss of 12.1%, while those on lower doses lost 9.2%. These findings are consistent with the STEP 2 trial, which compared 1 mg and 2.4 mg doses in patients with type 2 diabetes. Weight loss at 28 weeks was around 7% for the 1-mg group and 9.6% for the 2.4-mg group.
If your dosage is too low, you may not be experiencing the full appetite-suppressing or metabolic benefits of semaglutide.
2. You’re Not Following the Right Diet
Semaglutide may help reduce hunger, but it doesn’t control the type of food you choose. If you’re not following a structured, healthy diet, the results might not meet your expectations. For the best outcomes, focus on a balanced diet that includes plenty of vegetables, lean proteins, whole grains, and healthy fats.
A 2020 study showed that the Mediterranean diet had the most consistent and strongest evidence for reducing weight, BMI, cholesterol, blood sugar, and blood pressure. The DASH diet also suggested some benefits, particularly for weight and blood pressure.
In contrast, diets like low-carb, high-protein, low-fat, and low-glycemic had weaker or mixed results, especially for cholesterol, blood sugar, and blood pressure. Other diets, such as paleo, intermittent fasting, Nordic, vegetarian, and portfolio, had even less evidence supporting their benefits.
There isn’t a single definition of a healthy diet that works for everyone. Your weight loss plan should be personalized, and your nutritionist or physician can help create a plan that suits your specific needs.
Helpful Articles for Diabetics
If you’re also looking for more advice on managing diabetes through diet, check out these related articles:
These resources will help you make informed food choices for better health!
3. You’re Not Exercising Enough
If you’re not incorporating physical activity into your routine, it might be one of the reasons you’re not losing weight on Wegovy or Ozempic. Physical activity is an essential component in managing overweight or obesity, along with diet, behavioral support, and medical treatment. Exercise not only aids in weight loss but also helps reduce fat while preserving lean muscle mass.
Aerobic training has been shown to be particularly effective for weight loss. Studies indicate that it leads to greater weight and fat loss than resistance training, with a difference of approximately 1 kg (about 2.2 lbs). This difference is likely due to the higher energy expenditure during aerobic exercise compared to resistance training.
That said, both forms of exercise are important. The current recommendations for adults include 150-300 minutes of moderate-intensity aerobic activity per week, 75-150 minutes of vigorous-intensity aerobic activity, or a combination of both.
Additionally, adults should engage in muscle-strengthening activities targeting all major muscle groups at least two days per week. For individuals with diabetes, resistance exercise or short-distance running before aerobic activity can help prevent hypoglycemia.
4. You’re Not Taking Semaglutide Consistently
Semaglutide works best when taken consistently. Missing doses or not following the prescribed schedule can reduce the medication’s effectiveness. Skipping doses can lead to inconsistent GLP-1 hormone levels, which affect appetite control and metabolism.
Here’s what to do if you miss a dose of semaglutide:
- If your next scheduled dose is more than 48 hours (2 days) away, take the missed dose as soon as possible.
- If your next scheduled dose is within 48 hours, skip the missed dose and take your next dose on the regularly scheduled day.
- If you miss doses for more than 2 weeks, take the next dose on your usual day or contact your healthcare provider to discuss how to restart your treatment.
If you find it difficult to stick to a schedule, set reminders or alarms to ensure you take your medication on time. Keeping track of your medication schedule and staying consistent will help you get the best possible results.
Will You Gain Weight After Stopping Ozempic?
Explore the potential effects and what you should know about discontinuing this medication in this article: What Happens When You Stop Taking Ozempic
5. Your Metabolism Might Be Slower Than Others
Metabolism is the process by which your body converts food into energy. It runs continuously, even when you’re resting or sleeping, to power essential functions like breathing, blood circulation, and cell repair.
Metabolic rates vary among individuals. Some people naturally have slower metabolisms, making weight loss more challenging. While genes largely determine your metabolism, certain habits can slow it down further, such as:
-
- Eating too few calories
- Skipping protein
- A sedentary lifestyle
- Poor-quality sleep
- Drinking sugary beverages
- Lack of strength training
Making changes in these areas may help support a healthier metabolism.
6. Your Expectations May Be Unrealistic
It’s common to have high expectations when starting a new medication, but it’s important to keep realistic goals in mind. While semaglutide is effective, it’s not an overnight solution. Clinical studies show that average weight loss typically ranges from 5-15% of total body weight over several months.
For instance, in a study involving 1,306 patients taking 2.4 mg of semaglutide, participants lost around 6% of their body weight by week 12 and 12% by week 28. Additionally, how quickly you lose weight on Ozempic or Wegovy can vary significantly from person to person.
If you expect to lose weight quickly, you might feel disappointed. Remember that slow and steady progress is more sustainable in the long run. Stick with your plan, be patient, and understand that lasting weight loss takes time. Keep in touch with your healthcare provider to track your progress and make adjustments if needed.
7. You’ve Hit a Weight Loss Plateau
Every obesity intervention eventually results in a plateau, after which no further weight loss occurs despite continuing your diet or exercise program. Two popular theories can explain why weight loss plateaus happen:
-
- Set Point Theory: This idea suggests that your body has a “target” weight it wants to maintain. Your body uses signals from different parts, like fat tissue, to communicate with your brain. If you lose weight, your body tries to get back to that “set point” by making you hungrier or slowing your metabolism to keep things balanced.
-
- Settling Point Theory: This theory suggests that your body adjusts to changes in how much food you eat and the energy you use. There’s no direct feedback from your organs to your brain. Your metabolism adapts to the imbalance between energy intake (food) and output (activity) over time, which can cause weight loss to slow down or stop.
A recent study found that interventions like weight loss surgery and medications such as Wegovy and Zepbound can delay a plateau but don’t prevent it entirely.
To break through a plateau, you might need to change your calorie intake, exercise more, or tweak your diet. Plateaus can last anywhere from a few weeks to several months, and during this time, hormonal changes and mental challenges can make things more complicated. Getting help from a doctor, dietitian, or psychologist can provide helpful support during this stage.
8. You Could Have a Hormonal Imbalance
Both males and females with overweight or obesity face a higher risk of hormonal imbalances. In turn, these hormonal issues can make it harder to lose weight. They can slow down metabolism, boost appetite, and alter how the body stores fat.
If you suspect a hormonal issue, talk to your healthcare provider. They can run tests to identify any underlying conditions and recommend treatments or adjustments to help you overcome this barrier.
9. Emotional Eating or Stress Could Be Sabotaging Your Efforts
Your food intake isn’t always driven by physical hunger. Sometimes, you might eat for pleasure or as a form of reward, a behavior that’s common across many species. However, when this becomes a habit, it can lead to overeating and negatively impact your metabolism.
One example is emotional eating, often triggered by stress or negative emotions. It’s closely linked to weight gain and can make weight loss more difficult, even if you make positive lifestyle changes.
Research shows that semaglutide significantly reduced emotional eating in participants, from 72.5% down to 11.5%. However, some people still struggle with this issue, even after treatment. If you want to manage stress eating, here are some helpful tips:
-
- Identify your triggers by tracking when you emotionally eat.
- Find alternative activities like walking, yoga, or journaling to help cope.
- Practice mindful eating and pay attention to your hunger signals.
- Stay hydrated to avoid confusing thirst with hunger.
- Seek support from friends, family, or a therapist when needed.
- Allow yourself occasional treats in moderation to prevent feeling deprived.
Following these strategies can better control emotional eating and build healthier habits.
10. Medical Conditions or Medications May Be Interfering with Weight Loss
Certain medical conditions and medications can make it difficult to lose weight, even with semaglutide. Conditions like insulin resistance, sleep apnea, and gastrointestinal issues can hinder your progress.
Additionally, medications such as steroids, antidepressants, and antipsychotics are known to cause weight gain or make it harder to shed pounds.
If you have a medical condition or are taking medications that could be interfering with your weight loss, discuss this with your doctor. They might adjust your treatment plan or suggest alternative approaches to help you achieve your goals.
Reddit Discussions on Semaglutide and Weight Loss
In a subreddit discussion, a woman in her late 40s shares her frustration after taking Ozempic for nearly a year with minimal weight loss. She is puzzled about still feeling overweight, while others report better results.
I’m on Ozempic and I have barely lost any weight byu/oogiewoogie inrant
Another Reddit user shared their experience with Wegovy, explaining that they didn’t notice significant weight loss until reaching the 1.7 mg dose. Check out their personal insights in the discussion below:
No weight loss before 1.7mg of Wegovy byu/Repulsive-Rain4220 inWegovyWeightLoss
Final Words
Semaglutide can be a powerful tool for weight loss, but it’s important to understand that it’s not a magic solution. Several factors, such as dosage, calorie intake, physical activity, and emotional eating habits, can impact your progress.
If you’re not losing weight on Ozempic or Wegovy, consider these ten possible reasons and evaluate what changes you can make. Remember, weight loss is a journey that takes time. Stay patient, consistent, and proactive in making adjustments. More importantly, always consult with your healthcare provider to ensure you’re on the right track.
Frequently Asked Questions
Related Articles
Sources
Ghusn, W., De La Rosa, A., Sacoto, D., Cifuentes, L., Campos, A., Feris, F., Hurtado, M. D., & Acosta, A. (2022). Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity. JAMA Network Open, 5(9), e2231982. https://doi.org/10.1001/jamanetworkopen.2022.31982
Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., Rosenstock, J., Shimomura, I., Viljoen, A., Wadden, T. A., & Lingvay, I. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/s0140-6736(21)00213-0
Novo Nordisk. (2024). HIGHLIGHTS OF PRESCRIBING INFORMATION OF WEGOVY. Retrieved from https://www.novo-pi.com/wegovy.pdf
Dinu, M., Pagliai, G., Angelino, D., Rosi, A., Dall’Asta, M., Bresciani, L., Ferraris, C., Guglielmetti, M., Godos, J., Del Bo, C., Nucci, D., Meroni, E., Landini, L., Martini, D., & Sofi, F. (2020). Effects of Popular Diets on anthropometric and cardiometabolic parameters: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials. Advances in Nutrition, 11(4), 815–833. https://doi.org/10.1093/advances/nmaa006
Yang, Y. J. (2019b). An overview of current physical activity recommendations in primary care. Korean Journal of Family Medicine, 40(3), 135–142. https://doi.org/10.4082/kjfm.19.0038
Bellicha, A., Van Baak, M. A., Battista, F., Beaulieu, K., Blundell, J. E., Busetto, L., Carraça, E. V., Dicker, D., Encantado, J., Ermolao, A., Farpour?Lambert, N., Pramono, A., Woodward, E., & Oppert, J. (2021). Effect of exercise training on weight loss, body composition changes, and weight maintenance in adults with overweight or obesity: An overview of 12 systematic reviews and 149 studies. Obesity Reviews, 22(S4). https://doi.org/10.1111/obr.13256
Schwingshackl, L., Dias, S., Strasser, B., & Hoffmann, G. (2013). Impact of different training modalities on Anthropometric and Metabolic Characteristics in Overweight/Obese Subjects: A Systematic Review and Network Meta-Analysis. PLoS ONE, 8(12), e82853. https://doi.org/10.1371/journal.pone.0082853
Hall, K. D. (2024). Physiology of the weight?loss plateau in response to diet restriction, GLP?1 receptor agonism, and bariatric surgery. Obesity, 32(6), 1163–1168. https://doi.org/10.1002/oby.24027
Sarwan, G., & Rehman, A. (2022). Management of weight loss plateau. StatPearls – NCBI Bookshelf. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK576400/
Mazza, E., Troiano, E., Ferro, Y., Lisso, F., Tosi, M., Turco, E., Pujia, R., & Montalcini, T. (2024). Obesity, dietary patterns, and hormonal balance Modulation: Gender-Specific Impacts. Nutrients, 16(11), 1629. https://doi.org/10.3390/nu16111629
Nicolau, J., Pujol, A., Tofé, S., Bonet, A., & Gil, A. (2022). Short term effects of semaglutide on emotional eating and other abnormal eating patterns among subjects living with obesity. Physiology & Behavior, 257, 113967. https://doi.org/10.1016/j.physbeh.2022.113967
Campforts, B., Drukker, M., Crins, J., Van Amelsvoort, T., & Bak, M. (2023). Association between antipsychotic medication and clinically relevant weight change: meta-analysis. BJPsych Open, 9(1). https://doi.org/10.1192/bjo.2022.619
Morgan, C., Costello, R. E., Ray, D. W., & Dixon, W. G. (2019). How do glucocorticoids used in rheumatic disease affect body weight? A narrative review of the evidence. Arthritis Care & Research, 72(4), 489–497. https://doi.org/10.1002/acr.23879
Gafoor, R., Booth, H. P., & Gulliford, M. C. (2018). Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: population based cohort study. BMJ, k1951. https://doi.org/10.1136/bmj.k1951
